Dr. Ajay Jaysingh Khopade is a Vice President of R&D and Heading non-oral speciality division at Sun Pharmaceutical Industries Ltd (SPIL). He has over 26 years of experience in Sun Pharma in pharmaceutical product development. In his current role as VP-R&D, is responsible for the development of SPILs complex generic and specialty products. Dr. Khopade was a recipient of a prestigious lifelong Humboldt post-doctoral fellowship under which worked at the Max Plank Institute of Colloids and Interfaces, Germany. He is also a recipient of a prestigious JSPS fellowship from the Ministry of Japan. He acted as a board member of the European Union’s prestigious Marie-Curie Fellowship P4FIT programme. He is also on the academic board for MS University, NIPER, and various other colleges and institutes. Dr. Khopade has participated as a CMC expert in the submission of a number of INDs, NDAs to USFDA and other regulatory Agencies. He is an inventor of a platform nanotechnology in the field of oncology (Nanotecton®), ophthalmics (GFR®, SMM® Trisurf® and TearAct®) protected by various IPs globally with over a dozen patents. Most of these technologies are commercialized. He is a pharmaceutical and material scientist with an interest in understanding the physical chemistry of drug delivery system design.